#IORnews IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies. 🔗Learn more: ior.usi.ch/events-news/...

🌐 The IOR Foundation has a brand-new website! Discover more about our Foundation, which manages: - our Institute, the IOR - The International Extranodal Lymphoma Study Group (IELSG) - The International Conference on Malignant Lymphoma (ICML) 🔗 www.foundationior.ch

#IORnews The Lab of Prof. J.P. Theurillat together with Dr. M. Bolis created the Prostate Cancer Atlas, a web-based platform that empowers the research community to explore, compare, and analyze data with unprecedented ease and flexibility. 🔗 short-url.org/1ecu9 www.youtube.com/watch?v=qTjJ...

#IORnews A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL. Learn more: tinyurl.com/ytybcbr8

#IORnews The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies. 🔗Read more: ior.usi.ch/events-news/... @calcinottolab.bsky.social

#IORnews Dr. Perez joins the IOR with a prestigious international grant on drug repurposing for healthy aging, now supported by the SNSF through the Money Follows Researcher agreement. Read more: shorturl.at/pLKnm

#IORnews Among the 32 projects selected for funding in the first half of 2025 by the Swiss Cancer Research Foundation, are 3 research projects from the IOR, led by Prof. A. Alimonti, Prof. F. Bertoni and Prof. D. Rossi, focusing on lymphoma and prostate cancer. Read more: shorturl.at/xqmAd

Registration is open for the International Prostate Cancer Symposium (IPCS) 28–29 April 2026 – Lugano, Switzerland Held just before APCCC 2026, IPCS is your chance to explore next-gen treatments & breakthrough research in prostate cancer care. 🔗Register now: apccc.org

#IORjobs IOR invites applications from outstanding candidates interested in applying for the SNSF Ambizione and Marie Skłodowska-Curie Actions (MSCA) and EMBO fellowships. ⏳ IOR internal deadline: 3 August 2025 ➡️ Details & application procedure: shorturl.at/caVdu

#IORnews New study from Prof. Jean-Philippe Theurillat’s Lab maps proteomic changes in prostate cancer progression, revealing overlooked drivers of aggressiveness. 🔗 Read the news: shorturl.at/wZWou

The annual meeting of the Bellinzona Institutes of Science (Bios+) association, composed of the IOR and the Institute for Research in Biomedicine, took place on 4 June in Bellinzona. During the meeting, atty. G. Gendotti was appointed as the new Bios+ President. biosplus.ch/news-press/2...

The Foundation for the IOR is deeply saddened by the sudden passing of Prof. Esteban Cvitkovic on June 20, 2025. A passionate supporter of our Institute and, until recently, a highly active member of our Scientific Advisory Board, he played a key role in shaping our research. 🔗 shorturl.at/QSUKp

#IORnews The 18th edition of the International Conference on Malignant Lymphoma (18-ICML), one of the most prestigious global events dedicated to lymphoid malignancies, concludes today after a week of intense scientific exchange and groundbreaking presentations. 🔗 ior.usi.ch/events-news/...

#IORnews 🏆 Prof. F. Cavalli, President of the IOR Foundation, has been selected as the 2025 inductee in the Lymphoma category by the Giants of Cancer Care program, a prestigious recognition that honors the world’s most distinguished cancer researchers and clinicians. ➡️ Read more: shorturl.at/j7dbB

#IORnews A Swiss study led by Prof. Davide Rossi opens the door to a new opportunity for patients with relapsed chronic lymphocytic leukemia. 📄 Read more: shorturl.at/bokQS

𝗖𝗼𝗿𝘀𝗮 𝗱𝗲𝗹𝗹𝗮 𝗦𝗽𝗲𝗿𝗮𝗻𝘇𝗮 returns to Lugano on June 15, 2025, to celebrate 20 years of solidarity and movement for cancer research. We encourage you to participate in this meaningful event, because every step counts! 👉 See lnkd.in/gpa3cH29 for details about the programme and registration.

The countdown for the IBSA Foundation Forum is on – don’t miss it on 30 June 2025! More info: www.linkedin.com/posts/ibsa-f...

#IORjobs Open PhD Position! Join Arianna Baggiolini @ariannabaggiolini.bsky.social ’s Lab to work on human pluripotent stem cell (hPSC)-based models of the peripheral nervous system and disease. Info and application: ior.usi.ch/events-news/...

#IORnews 🎉 Congratulations to Dr. Bianca Calì, research associate in our Molecular Oncology Lab, for receiving the prestigious SAKK/Astellas GU-Oncology Award 2025! ➡️ Discover more about her winning study: shorturl.at/N2UaB

#IORnews Jonas Van Lent receives the Children's Tumor Foundation's Young Investigator Award. Congrats @jonasvanlent.bsky.social ! Read more: shorturl.at/ObLS5

The IOR is glad to host the SYIS Seminar today at 5PM CET, with Arianna Calcinotto as speaker. You can still join us in person or online via Zoom (check the image below for connection details).

#IORnews IOR researchers uncover a new mechanism linking senescent cells and immune suppression in prostate cancer, paving the way for improved therapies. ➡️ Discover more: shorturl.at/7PBJ0

#IORnews 🧬 New bioinformatic tool developed at IOR: EasyCircR. This open-source R package maps circRNA-miRNA-mRNA interactions, unlocking insights into gene regulation & cancer research. Discover more: shorturl.at/xjizN

Greetings from the Institute of Oncology Research (IOR) 👋 This is our official Bluesky account — stay tuned for updates, news, and insights from the Institute. Discover more at www.ior.usi.ch